Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial

CNBC CNBC —

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.

Read full article at CNBC →